Large-scale testing (Phase 3)Looking for participantsNCT03417622What this trial is testingWide Margin vs. Narrow Margin in Postneoadjuvant LumpectomyWho this might be right forBreast Cancer Mansoura University 370
Not applicableLooking for participantsNCT07327970What this trial is testingProspective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast CancerWho this might be right forBreast Cancer Young-Joon Kang 150
Large-scale testing (Phase 3)Looking for participantsNCT05633654What this trial is testingStudy of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)Who this might be right forTriple Negative Breast Cancer Gilead Sciences 1,514
Testing effectiveness (Phase 2)Study completedNCT00073073What this trial is testingExemestane and Celecoxib in Postmenopausal Women at High Risk for Breast CancerWho this might be right forBreast Neoplasms Georgetown University 46
Testing effectiveness (Phase 2)Looking for participantsNCT05861271What this trial is testingAdjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast CancerWho this might be right forBreast Cancer Stage I Fudan University 1,008
Testing effectiveness (Phase 2)Active Not RecruitingNCT03756298What this trial is testingEfficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast CancerWho this might be right forTriple Negative Breast Cancer National Cancer Center, Korea 284
Not applicableLooking for participantsNCT04074720What this trial is testingProspective Breast Cancer Biospecimen CollectionWho this might be right forBreast CancerInvasive Breast CancerCarcinoma in Situ of the Breast Thomas Jefferson University 200
Large-scale testing (Phase 3)Study completedNCT01583426What this trial is testingNanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)Who this might be right forTubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more GBG Forschungs GmbH 1,229
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06254066What this trial is testingAdebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast CancerWho this might be right forFemale Breast Cancer PatientsHistopathologically Confirmed Advanced HR +/HER2-invasive Breast CancerHRD Positive Advanced Breast Cancer Zhejiang Cancer Hospital 40
Large-scale testing (Phase 3)Active Not RecruitingNCT03414970What this trial is testingHypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerWho this might be right forDuctal Breast CarcinomaInvasive Breast CarcinomaLobular Breast Carcinoma+6 more Alliance for Clinical Trials in Oncology 898
Not applicableLooking for participantsNCT00437879What this trial is testingUltrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.Who this might be right forBreast Cancer Invasive Sunnybrook Health Sciences Centre 600
Not applicableEnded earlyNCT03480659What this trial is testingDetection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMCWho this might be right forBreast CancerBreast Cancer Female HKGepitherapeutics 165
Testing effectiveness (Phase 2)Active Not RecruitingNCT05545150What this trial is testingVolumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID StudyWho this might be right forAnatomic Stage 0 Breast Cancer AJCC v8Bilateral Breast CarcinomaBreast Ductal Carcinoma In Situ+3 more Northwestern University 113
Testing effectiveness (Phase 2)Temporarily pausedNCT06214793What this trial is testingTaletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)Who this might be right forBreast CancerMetastatic Breast Cancer Megan Kruse, MD 61
Early research (Phase 1)WithdrawnNCT06590558What this trial is testingTesting the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Carcinoma+9 more National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01846091What this trial is testingViral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHead and Neck Squamous Cell Carcinoma+8 more Mayo Clinic 12
Not applicableActive Not RecruitingNCT03503799What this trial is testingReaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast CancerWho this might be right forPrimary Invasive Breast CancerEstrogen Receptor Positive TumorHuman Epidermal Growth Factor Receptor 2 Negative Tumor North Eastern German Society of Gynaecological Oncology 1,191
Testing effectiveness (Phase 2)Study completedNCT00002873What this trial is testingRadiation Therapy in Treating Women With Stage I or Stage II Breast CancerWho this might be right forBreast Cancer Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT06961955What this trial is testing5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast CancerWho this might be right forBreast CancerInvasive Carcinoma of BreastDuctal Breast Carcinoma in Situ University of Utah 144
Not applicableLooking for participantsNCT07289282What this trial is testingCirculating microRNAs and Response to Neoadjuvant Chemotherapy in Breast CancerWho this might be right forBreast CancerNeoadjuvant TherapyPathological Response+2 more Atlas University 80